Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: Comparison between tissue-based and cell-based indirect immunofluorescence assays

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Chan, Koon H ^a   Kwan, Jason S C ^a   Ho, Philip W L ^a   Ho, Jessica W M ^a   Chu, Andrew C Y ^a   Ramsden, David B ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 AUTOANTIBODY; AUTOANTIBODY; AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CELL STRAIN HEK293; CEREBELLUM; CHINESE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONKEY; MYELITIS; MYELOOPTIC NEUROPATHY; NONHUMAN; OPTIC NEURITIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DEMYELINATING DISEASE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AQUAPORIN 4; AUTOANTIBODIES; BLOTTING, WESTERN; CHI-SQUARE DISTRIBUTION; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEK293 CELLS; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TRANSFECTION;

EID: 77956474797     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-50     Document Type: Article

References (37)

1. Devic E. Myelite subaigue compliquee de nevrite optique. Bull Med (Paris) 1894, 8:1033-1034.
2. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815. 10.1016/S1474-4422(07)70216-8, 17706564.
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
4. Cree BAC, Goodin DS, Hauser SL. Neuromyelitis Optica. Semin Neurol 2002, 22:105-122. 10.1055/s-2002-36534, 12524556.
5. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006, 77:1073-1075. 10.1136/jnnp.2005.080390, 2077753, 16505005.
6. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F, Verier A, Pruvo JP, Hache JC, Vermersch P. Devic's neuromyelitis: clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002, 197:57-61. 10.1016/S0022-510X(02)00043-6, 11997067.
7. Compston A, Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517. 10.1016/S0140-6736(08)61620-7, 18970977.
8. Chan KH, Ramsden DB, Yu YL, Kwok KH, Chu AC, Ho PW, Kwan JS, Lee R, Lim E, Kung MH, Ho SL. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders among Hong Kong Chinese. Eur J Neuro 2009, 16:310-316.
9. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G, . Italian Devic's Study Group (IDESG) Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 2004, 251:47-52. 10.1007/s00415-004-0271-0, 14999489, Italian Devic's Study Group (IDESG).
10. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112. 10.1016/S0140-6736(04)17551-X, 15589308.
11. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to aquaporin-4 water channel. J Exp Med 2005, 202:473-477. 10.1084/jem.20050304, 2212860, 16087714.
12. Nico B, Frigeri A, Nicchia GP, Quondamatteo F, Herken R, Errede M, Ribatti D, Svelto M, Roncali L. Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier. J Cell Sci 2001, 114:1297-1307.
13. Ami-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003, 4:991-1001. 10.1038/nrn1252, 14682361.
14. Nicchia GP, Nico B, Camassa LMA, Mola MG, Loh N, Dermietzel R, Spray DC, Svelto M, Frigeri A. The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience 2004, 129:935-945. 10.1016/j.neuroscience.2004.07.055, 15561409.
15. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, Hohlfeld R, Vincent A. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007, 68:1076-1077. 10.1212/01.wnl.0000256822.01222.bd, 17287449.
16. Jung JS, Bhat RV, Preston GM, Guggino WB, Baraban JM, Agre P. Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci USA 1994, 91:13052-13056. 10.1073/pnas.91.26.13052, 45579, 7528931.
17. Kim KK. NMO-IgG and opticospinal multiple sclerosis and idiopathic recurrent myelitis. Mult Scler 2006, 12:S157.
18. Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F, Saiz A. Neuromyelitis optica autoantibody (NMO-IgG) in patients with suspected NMO or limited forms of NMO. Mult Scler 2006, 12:S155.
19. Littleton ET, Jacob A, Boggild M, Palace J. An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica. Mult Scler 2006, 12:S3.
20. Marignier R, De Seze J, Vukusic S, Durand-Dubief F, Zephir H, Vermersch P, Cabre P, Cavillon G, Honnorat J, Confavreux C. NMO-IgG: a French experience. Mult Scler 2006, 12:S4.
21. Akman-Demir G, Mutlu M, Icoz S, Kurtuncu M, Yesilot N. Probable NMO IgG in Turkish patients with Devic's disease, and multiple sclerosis. Mult Scler 2006, 12:S157.
22. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern specific loss of aquaporin-4 immunoreactivity distinguish neuromyelitis optica from multiple sclerosis. Brain 2007, 130(5):1194-1205. 10.1093/brain/awl371, 17282996.
23. Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, Itoyama Y. Loss of aquaporin-4 active in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006, 209:269-275. 10.1620/tjem.209.269, 16778375.
24. Sinclair C, Kirk J, Herron B, Fitzgerald U, McQuaid S. Absence of aquaporin 4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol 2007, 113:187-194. 10.1007/s00401-006-0169-2, 17143632.
25. Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007, 13:256-259. 10.1177/1352458506070732, 17439893.
26. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005, 64:1270-1272.
27. Jacob A, Weinshenker BG, Violich I, McLinskey N, Frupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 2008, 65:1443-1448. 10.1001/archneur.65.11.noc80069, 18779415.
28. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective longitudinal study of seven patients treated with long-term immunosuppression. Neurology 1998, 51:1219-1220.
29. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 2007, 4:e133. 10.1371/journal.pmed.0040133, 1852124,1852124, 17439296.
30. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, Maxwell S, Beeson D, Vincent A. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008, 65:913-919. 10.1001/archneur.65.7.913, 18625857.
31. McKeon A, Fryer J, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ. Diagnosis of neuromyelitis spectrum disorders comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol 2009, 66:1134-1138. 10.1001/archneurol.2009.178, 19752303.
32. Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Yoshiyama Y, Mitsuoka K, Ishibashi K, Sasaki S, Hattori T, Kuwabara S. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008, 196:181-187. 10.1016/j.jneuroim.2008.03.009, 18462810.
33. Marnetto F, Hellias B, Granieri L, Frau J, Patanella AK, Nytrova P, Sala A, Capobianco M, Gilli F, Bertolotto A. Western blot analysis for the detection of serum antibodies recognizing linear aquaporin-4 epitopes in patients with neuromyelitis optica. J Neuroimmunol 2009, 217:74-79. 10.1016/j.jneuroim.2009.10.002, 19850359.
34. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243. 10.1093/brain/awm062, 17449477.
35. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489. 10.1212/01.wnl.0000216139.44259.74, 16717206.
36. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: revisions to the "McDonald Criteria". Ann Neurol 2005, 58:840-846. 10.1002/ana.20703, 16283615.
37. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:1-11.